Meeting
2021 ASCO Annual Meeting
Maintenance targeted therapy compared to standard of care (SoC) in patients (pts) with metastatic non-small cell lung cancer (NSCLC): Results from the phase II randomized UNICANCER/IFCT1301- SAFIR02-LUNG intergroup trial.
Authors
Benjamin Besse
Department of Medicine and Thoracic Pathology Committee, Gustave Roussy, Villejuif, France
Benjamin Besse , Maryam Karimi , Pascale Tomasini , Henri Janicot , Judith Raimbourg , Clarisse Audigier-Valette , Anne Madroszyk , Francois Chomy , Eric Dansin , Julien Mazieres , Alexis Cortot , Ivan Bieche , Ludovic Lacroix , Sandrine Boyault , Isabelle Soubeyran , Alain Morel , Alicia Tran-Dien , Alexandra Jacquet , Jean-Charles Soria , Fabrice Barlesi
Disclaimer
This material on this page is ©2024 American Society of Clinical Oncology, all rights reserved. Licensing available upon request. For more information, please contact licensing@asco.org
Poster Details
Session Type
Poster Session
Session Title
Lung Cancer—Non-Small Cell Metastatic
Track
Lung Cancer
Sub Track
Metastatic Non–Small Cell Lung Cancer
Clinical Trial Registration Number
2013-001653-27
Citation
J Clin Oncol 39, 2021 (suppl 15; abstr 9095)
DOI
10.1200/JCO.2021.39.15_suppl.9095
Abstract #
9095
Poster Bd #
Online Only
Abstract Disclosures
Similar Posters
Poster
2022 ASCO Annual Meeting
Evaluation of stage IV pancreatic adenocarcinomas based on mutational profiling of tumors.
First Author: Katherine E Poruk
Poster
2023 ASCO Quality Care Symposium
Real-world treatment patterns and clinical outcomes post standard of care (SOC) among patients (pts) with metastatic non-small cell lung cancer (mNSCLC) with and without actionable genomic alterations (AGAs) in the United States (US).
First Author: Ruchit Shah
Poster
2023 ASCO Annual Meeting
LIBELULE: A randomized phase III study to evaluate the clinical relevance of early liquid biopsy (LB) in patients with suspicious metastatic lung cancer.
First Author: Aurélie Swalduz
